Hoth Therapeutics Inc

NASDAQ:HOTH   3:59:53 PM EDT
1.32
-0.04 (-2.94%)
Products, Regulatory

Hoth Therapeutics Announces Positive Confirmatory Results From In Vivo Model Of HT-003 Assets

Published: 07/13/2021 12:26 GMT
Hoth Therapeutics Inc (HOTH) - Hoth Therapeutics Announces Positive Confirmatory Results From in Vivo Model of Ht-003 Assets As Potential Treatment Against Acne.
Hoth Therapeutics Inc - Study Also Showed That Ht-003 Reduces Expression of Numerous Cytokines Critical for Acne Pathophysiology.
Hoth Therapeutics Inc - is Exploring Potential Application of Ht-003 Assets in Inflammatory Bowel Disorders (ibds).